Ardelyx
Ardelyx is a Biotechnology company enabled to develop a pipeline of drug candidates designed to better manage complications related to kidney and cardiorenal diseases. The headquarters is in USA.
Ardelyx Annual Total Revenue for year ending Dec-2022 was 52 million USD and and Net loss for year ending Dec-2022 was -67 million USD.
Ardelyx Annual Total Revenue for year ending Dec-2021 was 10 million USD and and Net loss for year ending Dec-2021 was -158 million USD.
As on 2022, Ardelyx has 133 employees.